logo
HDB Listing: Are unlisted shares the new road to high gains? Check this before investing

HDB Listing: Are unlisted shares the new road to high gains? Check this before investing

Time of India5 days ago
Academy
Empower your mind, elevate your skills
Investment into unlisted companies is gaining momentum among investors in India as they intend to gain substantially by the time the listing happens. It has potential to deliver double advantage to investors one, valuation gains before the listing and second the listing premium when the company goes for an IPO.A flurry of initial public offering (IPO) listings is expected this week, with several companies set to debut on the stock exchanges. Among the most anticipated was HDB Financial Services , the non-banking arm of HDFC Bank, which attracted strong investor interest ahead of its listing. Other notable companies hitting the market include Kalpataru Projects and Ellenbarrie Industrial Gases, making it one of the most active weeks for primary markets in recent months.Shares of HDB Financial Services, a non-banking financial company (NBFC) and subsidiary of HDFC Bank, listed at a premium of 12.84% (up Rs 95) today (July 02,2025), opening at Rs 835 on both the NSE and BSE, against an issue price of Rs 740. The company's IPO issue was subscribed 17.65 times overall, led by Qualified Institutional Buyers (QIBs) who bid 58.6 times their portion. Non-institutional investors subscribed 10.5 times, while retail interest was more muted at 1.5 times. However, has this listing proven to be a good bet by investors who bought the unlisted share of this company much before its listing. Not necessarily, if you were driven by euphoria you may have ended up buying this unlisted company at a steeper price than what was discovered on the day of listing.Lovaii Navlakhi, Managing Director & CEO of International Money Matters, says, 'In unlisted shares , the FOMO effect results in a very high weightage on sentiment, sometimes ignoring the rest. This has resulted in HDB Financial shares trading at 1200 in the grey market and finding the issue at 740. Retail investors must surely give up investing in unlisted shares - as they cannot stomach the risk of a large fall - there is a reason why this is called grey market -- it's not black, but it's certainly not white.''HDB Financial Services was one of the most liquid scripts in the unlisted market trading in the range of Rs 700-1400 in the last one year before the IPO price band announcement. HDB enjoys its parent company's brand trust and thus, it has been one of the most awaited IPO this year,' says Manish Goel, Founder & MD, Equentis Wealth Advisory Services Limited.Investor sentiment has limited role to play as valuation of a company depends largely on its fundamentals. 'We have to understand how shares are valued: Based on profits of companies, how their competitors ar rated, the future of the industry, profit growth in the past and expectations, and sentiment are some of the bases,' says Navlakhi.For investors of HDB Financial Services, the Rs 740 price band for the company's IPO is 40% lower than the Rs 1,225 levels it was fetching just days ago in the unlisted market. Investors who bought last year at Rs 1,550 will have to face a 52% loss in value before the IPO even gets listed on the exchanges.Manish Goel adds, 'On the pricing, we are seeing an increasing trend of IPOs being priced at a discount of 25-40% for higher investor participation which largely gets adjusted on the listing day to some extent. It's worth noting that a similar scenario occurred with Waaree Energies late last year where the unlisted price was around Rs 2,500, and the IPO was priced at Rs 1,500 per share, only to list at Rs 2,500 and presently trading higher.'Retail investors showed significant interest in buying pre-IPO shares of HDB Financial Services. However, their response to the company's IPO was lukewarm. 'Many companies pursue pre-IPO sales because they sense that public market demand may not be as exuberant as expected, and they want to lock in valuations while investor sentiment is still warm. HDB Financial's tepid IPO oversubscription (by retail investors) compared to the frenzy in its unlisted shares underscores this dynamic,' says Mohit Bhandari, CEO of Stratzy, a financial technology startup.Exclusive access offered to investors to buy unlisted shares, has an overpowering impact on their judgement about fair valuation of the company. 'Retail investors often get lured by the illusion of exclusivity in pre-IPO stocks, forgetting that liquidity can remain a chronic problem—just look at Chennai Super Kings shares languishing without an exit or PharmEasy's steep valuation slide after early trades,' says Mohit Bhandari, CEO of Stratzy, a financial technology startup.We are now getting more and more cases where such investors of unlisted companies are getting a humbling experience about the gains at the time of IPO which did not turn out the way they had anticipated. 'In case of HDB as well, we saw some resentment around the IPO price band being 30-40% lower than unlisted market price. Though it opened 13.5% up today on listing. We remain of the view that HDB is currently trading near its fair value and to a discount to both its peers Bajaj Finance and CholaFin, which is justified by the difference in customer profile and return metrics,' says Goel.Bhandari further adds, 'In the end, why chase the mirage of low-liquidity pre-IPO bets when there are so many established, regulated companies already listed with transparent price discovery? If you truly want to back early-stage businesses, angel investing might be a more honest path than buying pre-IPO shares from someone trying to de-risk their own exposure. Investors should ask themselves whether they're buying into a promising company or simply providing an exit for someone else. Mohit Bhandari, CEO, Stratzy, a financial technology startup.'Investing in unlisted shares has many pitfalls which investors must factor in. Investing in unlisted shares can be far riskier than it seems at first glance. Narendra Solanki, Head Fundamental Research- Investment Services, Anand Rathi Shares and Stock Brokers underlined the risks of investing in shares of unlisted companies. 'Prices in the unlisted market aren't transparent, they're often driven by sentiment, hype, or insider news, making them prone to manipulation. Liquidity is another big issue; you can't always buy or sell when you want, as these trades usually happen through market intermediaries, not an open exchange. There's also a lack of transparency, with many deals not publicly documented, and a real risk that the person selling you the shares may not deliver them even after receiving payment.'The risks don't end here. 'Valuing unlisted companies is tricky too, especially if there are no listed peers to compare with. On top of that, private firms don't have to follow the same disclosure norms as listed companies, so you may not get regular updates on their financials or business health. There's also the chance that the company may never list, leaving you stuck with shares you can't exit. Your stake could get diluted if the company issues more shares in future rounds. And without any direct regulatory or exchange oversight, there could be other hidden risks that aren't obvious at the time of investing,' says Solanki.In a recent post on X (formerly Twitter), Zerodha founder Nithin Kamath also highlighted the risks of investing in unlisted shares and said that many retail investors buy into these shares based on hype and expected listing gains, often without fully understanding the business or its fundamentals. He also cited the example of HDB Financial Services, whose shares were trading at a premium of nearly ₹1,100 in the unlisted market just a few years ago, far higher than the IPO price of ₹740 per share. This, he said, shows how unlisted shares can be significantly overpriced, leaving investors exposed to potential losses.Kamath warned that the unlisted space lacks transparency, has low liquidity, and operates without much regulatory oversight, which makes it riskier than the regular stock market. He urged investors to exercise caution, avoid getting swayed by brand value or social media hype, and conduct proper due diligence before investing in unlisted companies.Ladder7 Wealth Planners Private Limited's MD and Principal Officer Suresh Sadagopan chimes in with his views, 'There is no price discovery mechanism and the unlisted prices can be unrealistically high, resulting in losses on listing. Liquidity is low; one may not be able to sell them. IPO may not come up as expected and if there is lack of liquidity, one can get stuck for long.'Investors often carry unrealistic expectations when entering the unlisted space. 'Investments in unlisted companies are done with the assumption that one will get it cheap and there would be listing gains. But it is not always true like in the case of HDB & Swiggy. What is going to happen in NSE's case will be interesting to watch, with all the hype and excitement around that share, Sadagopan added.Swiggy, which went public in November 2024, listed at Rs 412 on the BSE at a 7% premium over its IPO price of Rs 390. Following shareholder approval for an IPO in April, the company's stock witnessed significant interest in the unlisted market, resulting in a substantial increase in share prices, as per an Economic Times report. From July to September, its shares surged by nearly 40%, rising from Rs 355 to Rs 490 approximately. However, the shares have had a rough time since the listing, having plummeted by about 39% since then. In 2025 alone, the stock as lost 41% of its value.HDB Financial Services launched its much-anticipated Rs 12,500-crore IPO from June 25 to June 27. The offer included a fresh issue of Rs 2,500 crore and an offer for sale of Rs 10,000 crore by HDFC Bank, with the price fixed at Rs 740 per share. The IPO drew strong interest across many investor categories, receiving over 42.6 lakh applications.While high-profile listings often generate buzz, investors should be cautious when dealing with unlisted shares or grey market premiums. Prices can be volatile, and without regulatory oversight, there's a higher risk of overpaying or falling for speculative hype before the stock actually lists.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Crizac IPO allotment date likely today. Latest GMP, steps to check share allotment status online
Crizac IPO allotment date likely today. Latest GMP, steps to check share allotment status online

Mint

time42 minutes ago

  • Mint

Crizac IPO allotment date likely today. Latest GMP, steps to check share allotment status online

Crizac IPO Allotment: The initial public offering (IPO) of B2B education platform Crizac Ltd receives strong demand during its subscription period. As the bidding has ended, investors now focus on the Crizac IPO allotment date. The public issue was open from July 2 to 4. Crizac IPO allotment date is likely today, July 7, and the IPO listing date is expected to be July 9. The company is expected to finalise the Crizac IPO allotment status soon. Once the Crizac IPO allotment status is fixed, it will then credit the equity shares into the demat accounts of the allotment holders, and initiate refunds to the unsuccessful bidders. Investors can check Crizac IPO allotment status online through the websites of BSE and NSE, along with the official portal of IPO registrar. MUFG Intime India Private Limited (Link Intime) is the Crizac IPO registrar. In order to do Crizac IPO allotment status online check, investors must follow a few simple steps mentioned below. Step 2] Select 'Equity' in the Issue Type Step 3] Choose 'Crizac Limited' in the Issue Name dropdown menu Step 4] Enter either Application No. or PAN Step 5] Verify by ticking on 'I am not robot' and click on 'Search' Your Crizac IPO allotment status will be displayed on the screen. Step 2] Select 'Equity and SME IPO bids' Step 3] Choose 'Crizac Limited' from the Issue Name dropdown menu Step 4] Enter your PAN and Application Number Your Crizac IPO allotment status will be displayed on the screen. Step 2] Choose 'Crizac Limited' in the Select Company dropdown menu Step 3] Select among PAN, App. No., DP ID or Account No. Step 4] Enter the details as per the option selected Your Crizac IPO allotment status will be displayed on the screen. Crizac shares are showing a bullish trend in the grey market. According to market experts, Crizac IPO GMP today, or grey market premium today, is ₹ 43 per share. This means that Crizac shares are available at a premium of ₹ 43 to their issue price in the grey market. Considering Crizac IPO GMP today, the estimated listing price of Crizac shares would be ₹ 288 apiece, which is at a premium of 17.55% to the IPO price of ₹ 245 per share. The public issue of the B2B education platform opened on July 2, and closed on July 4. Crizac IPO allotment date is likely today, 7 July 2025, and the IPO listing date is July 9. Crizac IPO price band was ₹ 245 per share. The company raised ₹ 860 crore from the book-building issue which was entirely an offer-for-sale of 3.51 crore equity shares. Crizac IPO was subscribed 59.82 times in total as the offer received bids for 154.56 crore shares as against 2.58 crore shares on offer, NSE data showed. The retail portion was booked 10.24 times while the non-institutional investor (NII) quota was subscribed 76.15 times. The qualified institutional buyers (QIB) segment received 134.35 times bids. Equirus Capital is the book-running lead manager of the Crizac IPO, while MUFG Intime India (Link Intime) is the IPO registrar. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Sebi's Jane Street interim order made India's stock market sit up for good reason
Sebi's Jane Street interim order made India's stock market sit up for good reason

Mint

time42 minutes ago

  • Mint

Sebi's Jane Street interim order made India's stock market sit up for good reason

The stock market has been forced to sit up by an interim order passed by the Securities and Exchange Board of India (Sebi) against New York-based securities firm Jane Street. The order has fired the imagination of sundry arbitrageurs and mollified traders who were alarmed by rising levels of risk in India's capital markets. Sebi has been alerting the public about rising risk in the equity futures and options (F&O) segment and taking prudential steps. Last week, after a long probe, it barred Jane Street's four trading arms from transacting in the Indian securities markets till it completes its 'detailed' investigation. The capital market regulator has also sought to disgorge ₹4,844 crore from the securities firm. Sebi's order alleges that Jane Street's associate arms indulged in market manipulation—specifically of Bank Nifty index derivatives and this index's constituent shares in the cash segment. Also Read: Mint Explainer: How Sebi sniffed out Jane Street's market manipulations Jane Street allegedly ignored a February advisory from the first-level regulator, National Stock Exchange (NSE), leading Sebi to comment in its order that it is not 'a good faith actor that can be, or deserves to be, trusted." The whole affair not only raises many questions, but points to some macro issues as well. The first question arises from the way in which Sebi chanced upon Jane Street's alleged misconduct. Media reports in April 2024 detailed how Jane Street had sued two former employees in a Manhattan court for allegedly using the firm's 'proprietary trading strategy' in their new firm. The lawyers of the accused revealed in court that the strategy was being deployed in India. This reportage alerted Sebi, which then began its initial probe into Jane Street's trades in the Indian market's cash and derivative segments, which included directing NSE to keep a close watch on the firm's trading patterns. While Sebi must be lauded for its alacrity and the time it took to marshal and establish the facts of this case—from April 2024 to July 2025—a question could be raised about its source of information. To be fair, Sebi can always respond to alerts of any viable origin. However, Jane Street's trading strategy was at work for more than a year before April 2024, having flown below Sebi's vigilance and surveillance radars. Thereby hangs a lesson. Also Read: Street theatre: Sebi pins down Jane Street for manipulation Another issue that should be debated is whether Jane Street's trading strategy was illegal—or 'manipulation" as per the Indian regulator's interim order. Many F&O traders have adopted similar strategies in the past and escaped scrutiny. Jane Street's large volumes in a shallow market made the difference; but then, can the securities firm be blamed for structural deficiencies in our derivatives market? What's more important, though, is the fact that Jane Street allegedly profited on the back of uninformed derivatives trading by retail investors. Sebi's September 2024 report had stated that over 90% of retail investors in the F&O market had incurred losses between 2021-22 and 2023-24. This then calls for a larger investigation into whether retail investors were led up the garden path and if the entities that operated as pied pipers were acting on behalf of Jane Street. Also Read: F&O action: Can new Sebi rules tame wild bulls of the derivatives market? Sebi's F&O risk mitigation strategy, which has included raising the bar for futures and options trading, may need some course correction. The regulator must ensure that the bar is raised sufficiently to deter non-institutional investors from treating the derivatives segment of the market like a casino without a cover charge.

Chemkart India IPO: Check GMP, price band and other details
Chemkart India IPO: Check GMP, price band and other details

Economic Times

time43 minutes ago

  • Economic Times

Chemkart India IPO: Check GMP, price band and other details

Mumbai's Chemkart India, a B2B food and health ingredient distributor, is launching its IPO today. The company aims to raise Rs 80.08 crore. The IPO includes a fresh issue and an offer for sale. The issue closes on July 9, with BSE SME listing expected on July 14. Proceeds will fund expansion and debt repayment. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Chemkart India, a Mumbai-based B2B distributor of food and health ingredients, will open its IPO today, aiming to raise Rs 80.08 crore through a mix of fresh issue and offer for sale. The three-day issue will close on July 9, with shares expected to list on the BSE SME platform on July IPO comprises a fresh issue of 26 lakh shares aggregating up to Rs 64.48 crore and an offer for sale (OFS) of 6.29 lakh shares worth Rs 15.60 price band is fixed at Rs 236–248 per share, with a lot size of 600 shares. Ahead of the issue opening, the GMP is Rs 0 in the unlisted Horizon Capital Advisors is the lead manager to the issue, with Bigshare Services as registrar. Alacrity Securities is the market in 2015, Chemkart operates in the health and food ingredients segment, supplying amino acids, herbal extracts, vitamins, proteins, and sports nutrition components to supplement company also offers in-house services like grinding, blending, and packaging at its 28,000 sq. ft. facility in Bhiwandi, enhancing its control over quality and IPO proceeds will fund capital expenditure through investment in its wholly owned subsidiary, Easy Raw Materials, repay existing borrowings, and meet general corporate of FY25, Chemkart reported a 55% jump in revenue to Rs 205.46 crore and a 67% rise in profit after tax at Rs 24.26 crore. Its return on equity stands at 59%, with a healthy EBITDA margin of 16.12%.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store